Vaspin transgenic mice prevented diet-induced obesity, glucose intolerance, and hepatic steatosis, while vaspin-deficient mice developed glucose intolerance associated with up-regulation of ER stress markers [21]. This evidence concerns the gene SERPINA12 and fatty liver disease.